Nucleic Acids Research, 2001, Vol. 29, No. 2 415-422
© 2001 Oxford University Press
Effect of 2'-O-methyl antisense ORNs on expression of thymidylate synthase in human colon cancer RKO cells
Department of Medicine and Pharmacology, Yale Cancer Center, Yale University School of Medicine and VA Connecticut Healthcare System, New Haven, CT 06520, USA and 1Hybridon, Inc., Cambridge, MA 02139, USA
Translation of thymidylate synthase (TS) mRNA is controlled by its own protein end-product TS in a negative autoregulatory manner. Disruption of this regulation results in increased synthesis of TS and may lead to the development of cellular drug resistance to TS-directed anticancer agents. As a strategy to inhibit TS expression, antisense 2'-O-methyl RNA oligoribonucleotides (ORNs) were designed to directly target the 5' upstream cis-acting regulatory element (nucleotides 80–109) of TS mRNA. A 30 nt ORN, HYB0432, inhibited TS expression in human colon cancer RKO cells in a dose-dependent manner but had no effect on the expression of ß-actin, 
-tubulin or topoisomerase I. TS expression was unaffected by treatment with control sense or mismatched ORNs. HYB0504, an 18 nt ORN targeting the same core sequence, also repressed expression of TS protein. However, further reduction in oligo size resulted in loss of antisense activity. Following HYB0432 treatment, TS protein levels were reduced by 60% within 6 h and were maximally reduced by 24 h. Expression of p53 protein was inversely related to that of TS, suggesting that p53 expression may be directly linked to intracellular levels of TS. Northern blot analysis demonstrated that TS mRNA was unaffected by HYB0432 treatment. The half-life of TS protein was unchanged after antisense treatment suggesting that the mechanism of action of antisense ORNs is mediated through a process of translational arrest. These findings demonstrate that an antisense ORN targeted at a critical cis-acting element on TS mRNA can specifically inhibit expression of TS protein in RKO cells.
* To whom correspondence should be addressed. Tel: +1 203 937 3421; Fax: +1 203 937 3803; Email: chueyale{at}yahoo.com
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Papucci, E. Witort, A. M. Bevilacqua, M. Donnini, M. Lulli, E. Borchi, K. S. A. Khabar, A. Tempestini, A. Lapucci, N. Schiavone, et al. Impact of Targeting the Adenine- and Uracil-Rich Element of bcl-2 mRNA with Oligoribonucleotides on Apoptosis, Cell Cycle, and Neuronal Differentiation in SHSY-5Y Cells Mol. Pharmacol., February 1, 2008; 73(2): 498 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Flynn, R. W. Berg, T. Wong, M. van Aken, M. D. Vincent, M. Fukushima, and J. Koropatnick Therapeutic potential of antisense oligodeoxynucleotides to down-regulate thymidylate synthase in mesothelioma. Mol. Cancer Ther., June 1, 2006; 5(6): 1423 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-H. Chi, H.-E. Wang, Y.-S. Wang, S.-L. Chou, H.-M. Yu, Y.-H. Tseng, I.-M. Hwang, and W.-Y. Lui Antisense Thymidylate Synthase Electrogene Transfer to Increase Uptake of Radiolabeled Iododeoxyuridine in a Murine Model J. Nucl. Med., March 1, 2004; 45(3): 478 - 484. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. C. Schmitz, T.-m. Chen, and E. Chu Small Interfering Double-Stranded RNAs as Therapeutic Molecules to Restore Chemosensitivity to Thymidylate Synthase Inhibitor Compounds Cancer Res., February 15, 2004; 64(4): 1431 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Holmes, A. A. Arzumanov, and M. J. Gait Steric inhibition of human immunodeficiency virus type-1 Tat-dependent trans-activation in vitro and in cells by oligonucleotides containing 2'-O-methyl G-clamp ribonucleoside analogues Nucleic Acids Res., June 1, 2003; 31(11): 2759 - 2768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-C. Mou and D. M. Gray The high binding affinity of phosphorothioate-modified oligomers for Ff gene 5 protein is moderated by the addition of C-5 propyne or 2'-O-methyl modifications Nucleic Acids Res., February 1, 2002; 30(3): 749 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Berg, M. Werner, P. J. Ferguson, C. Postenka, M. Vincent, D. J. Koropatnick, and E. Behrend Tumor Growth Inhibition in Vivo and G2/M Cell Cycle Arrest Induced by Antisense Oligodeoxynucleotide Targeting Thymidylate Synthase J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 477 - 484. [Abstract] [Full Text] [PDF]
|
|